Alternative models were explored in the sensitivity analysis as follows: (1) non-linearity. We fitted a "lowness" curve to each patient's data (not reported) and checked if the assumption of two linear trends before/after human foetal striatal transplantation would be reasonable. We also fitted a non-linear non-parametric model (by a cubic spline with 5 knots) over time since onset of symptoms. The transplantation effect changed from -0.9 (95%CI -1.6;-0.2) to -1.0 (95%CI -1.9;-0.2) for total motor scores and from 2.7 (95%CI 0.1;5.3) to 3.0 (95%CI 0.2;5.8) for total cognitive scores. (2) The goodness-of-fit R-squared based on the log-likelihood ratio was 0.76 for total motor and 0.56 for total cognitive scores. The change-in-slope was -0.8 (-1.4;-0.2) (deleting 7 outlying/influential observations) vs. -0.9 (-1.6;-0.2) for total motor score, and 3.9 (95%CI 1.7;6.2) (deleting 4 observations) vs. 2.7 (0.1;5.3) for total cognitive score. (3) The inclusion of a subject-specific random effect for deterioration over time did not alter the main results -for total motor scores on the whole patients' series the change-in-slope was -1.1 unit/year (95% CI -1.9;-0.4) vs. -0.9 (-1.6;-0.2). (4) heterogeneity among subjects of transplantation effect. Fitting a random slope model for foetal striatal grafting, we still found a transplantation effect on average (the change-in-slope is -1.5 unit/year, 95% CI -2.7;-0.3 for total motor scores) and a heterogeneity standard deviation of 0.56 years. The change-in-slope 80% population interval is -1.5  0.56 × 1.282 = -0.8;-2.2 unit/year. That is 80% of patients had a predicted transplantation effect between -0.8 and -2.2 and 10% above -0.8. Since a clinically significant effect (Table 3B of the main manuscript) is recorded for a change-in-slope of -0.8 or less, we estimated that one patient in 10 will not experience a clinical benefit. (5) confounding control. We used a propensity score for total motor scores which included age at onset, sex, disease burden at onset, time since onset of symptoms and total cognitive scores. The change-in-slope was -0.7 (95%CI -1.5;0.0) instead of -0.9 (-1.6;-0.2). (6) standard errors estimates. We have a relatively small sample size and multivariate models, we checked the stability of our results, especially for accurate estimate of standard errors, by using a bootstrap/jackknife approach (for total motor score the standard error for the changein-slope was 0.41 vs. 0.37 and the 95%CI were -1.7;-0.1 vs. -1.6;-0.2).
equipped with ultra-high resolution collimators. Image data were reconstructed using FBP algorithm and corrected for attenuation using Chang algorithm (μ=0.12 cm -1 ). VOIs were drawn on the striata (caudate nucleus and putamen) and the cerebellum. Mean voxel values within each VOI were extracted from SPECT images and ratio of striatal values to the cerebellum was calculated to estimate D 2 receptor density.
Protocol of foetal tissue collection and preparation[1-3]
Foetal striatal tissue was obtained from the brains of legally aborted foetuses, according to the guidelines of the National Institute of Health (MD, USA). The use of human fetal tissue for research purposes was approved by the National Ethics Committee and the Committee for investigation in Humans of the University of Florence.
Maternal donor serum was tested for a range of pathogens (HbsAg/Hb Ag HCV, HIV 1-2, HTLV I -II, CMV, toxoplasmosis and TPHA). Screening results were available prior to tissue collection. Permission to collect tissue from the maternal donor was requested and obtained at the end of the abortion procedure. For each procedure, both whole ganglionic eminencies were dissected from the floor of the forebrain ventricles.
Estimation of fetal gestational age was determined by multiple parameters. [4] Immediately after isolation, the tissue was placed in 500 μl of physiological solution at 4°C and cut into small fragments, gently dissociated using firepolished Pasteur pipettes of decreasing bore diameters. Dissociated cells from striatal fragments were re-suspended in 500 μl of physiological solution (final grafting suspension) and triturated 5-10 times using a 200 μl disposable plastic pipette tip. Total nucleated cells were diluted 1:10 by trypan blue dye and transferred in a Burker chamber for counting at optic microscope. The average number of cells of 4 large squares has been used to calculate the cell concentration. A small aliquot was taken for assessment of cell viability by trypan blue dye exclusion and 7-Actinomycin D test, and a second aliquot was used for immuno-phenotype profile. A residual aliquot, after transplantation, was used for microbiological culturing (aerobic and anaerobic bacterial cultures). Another portion of the fetal tissue was used for HLA typing and for CAG-repeat count at the HD locus.
